|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Selection of IgG properties for therapeutic applications
If you have a question about this talk, please contact Sue Griffin.
Host: Jim Kaufman (firstname.lastname@example.org)
This talk will give the background and an overview to work on the selection and engineering of IgG Fc regions for therapeutic applications.
Examples will include selection of Fc regions for the commercially developed antibodies alemtuzumab (CD52), otelixizumab (CD3) and tanezumab (NGF), as well as antibodies to the red cell antigen RhD, and the platelet alloantigen HPA -1a.
This talk is part of the Immunology in Pathology series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsQuaternary Discussion Group (QDG) Modern British craft re-displayed Public Understanding of Risk
Other talksTissue Engineering Today TBC 'Unorthodox Memories: Baptist Accounts of the Soviet Past' - Miriam Dobson Scientific Approaches to Musical Improvisation A genomic survey of the machineries that control & link cell shape, microtubules & cell cycle progression Characterisation of clean and silty-sands using variable penetration rate cone testing